View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 13, 2023
1 min read
Save

Higher 30-day mortality, poor outcomes linked to early surgery in older adults with TBI

Higher 30-day mortality, poor outcomes linked to early surgery in older adults with TBI

In older adults with traumatic brain injury and acute subdural hematoma, early neurosurgical intervention resulted in the highest 30-day mortality rates, while delayed surgery yielded better outcomes.

SPONSORED CONTENT
April 13, 2023
2 min read
Save

Systolic BP should not inform decision to withhold, delay endovascular thrombectomy

Systolic BP should not inform decision to withhold, delay endovascular thrombectomy

High or low systolic blood pressure on hospital admission did not negate the effects of endovascular thrombectomy in patients with ischemic stroke, although higher levels were associated with worse functional outcomes.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
April 13, 2023
5 min read
Save

When evaluating financial advisors, understand how they make money

When evaluating financial advisors, understand how they make money

Today’s economic environment and market volatility have caused many DIY investors to reconsider working with professional financial advisors. Those who work with advisors also may be evaluating their advisor and investigating alternatives.

SPONSORED CONTENT
April 12, 2023
2 min read
Save

Umbrella review finds ‘inconclusive evidence’ supporting cognitive benefits of exercise

Umbrella review finds ‘inconclusive evidence’ supporting cognitive benefits of exercise

After re-examining more than 20 meta-analyses of randomized controlled trials, researchers said they found “inconclusive evidence” supporting a positive link between regular physical exercise and cognition in healthy participants.

SPONSORED CONTENT
April 12, 2023
1 min read
Save

FDA places partial clinical hold on initiation of new patients in evobrutinib study

FDA places partial clinical hold on initiation of new patients in evobrutinib study

Merck KGaA announced the FDA has paused the initiation of new patients on evobrutinib for relapsing-remitting MS, as well as those with less than 70 days exposure to the treatment in the United States.

SPONSORED CONTENT
April 12, 2023
1 min read
Save

FDA grants fast track designation for novel Duchenne muscular dystrophy gene therapy

FDA grants fast track designation for novel Duchenne muscular dystrophy gene therapy

Regenxbio Inc. announced that the FDA has granted fast track designation for RGX-202, a one-time gene therapy for treatment of Duchenne muscular dystrophy.

SPONSORED CONTENT
April 12, 2023
1 min read
Save

FDA grants 510(k) clearances to triage, notification findings on chest, head imaging

FDA grants 510(k) clearances to triage, notification findings on chest, head imaging

The FDA has granted 510(k) clearances to seven triage and notification findings of varying conditions on chest X-ray and head CT images, according to a manufacturer-issued press release.

SPONSORED CONTENT
April 11, 2023
2 min read
Save

More than 40% of patients with long COVID report mild to severe sleep disturbances

More than 40% of patients with long COVID report mild to severe sleep disturbances

More than 40% of patients with long COVID reported having mild to severe sleep disturbances, with Black individuals and those hospitalized for COVID-19 at greater risk for worsened sleep, a recent study found.

SPONSORED CONTENT
April 11, 2023
1 min read
Save

Neurostimulation device reduces seizure frequency in adults with drug-refractory epilepsy

Neurostimulation device reduces seizure frequency in adults with drug-refractory epilepsy

In adults with drug-refractory focal epilepsy, treatment with an implanted neurostimulation device was safe and associated with significant reduction in seizure frequency, according to a study published in JAMA Neurology.

SPONSORED CONTENT
April 11, 2023
1 min read
Save

Phase 1/2a trial commenced for Alzheimer’s dementia immunotherapy

Phase 1/2a trial commenced for Alzheimer’s dementia immunotherapy

Alzamend Neuro Inc. announced initiation of a phase 1/2a clinical trial for its proprietary immunotherapy vaccineALZN002 to treat mild to moderate dementia associated with Alzheimer’s disease.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails